» Articles » PMID: 17350498

Chromoblastomycosis

Overview
Journal Clin Dermatol
Publisher Elsevier
Specialty Dermatology
Date 2007 Mar 14
PMID 17350498
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Chromoblastomycosis is a chronic subcutaneous mycotic infection caused by pigmented or dematiaceous saprophytic moulds ubiquitous in the environment. The most common etiologic agents are Fonsecaea pedrosoi and Cladophialophora carrionii, both of which can be isolated from plant debris. The infection usually follows traumatic inoculation through penetrating thorn or splinter wounds. The fungal agents develop as small clusters of cells known as muriform bodies. Several months after the injury, painless papules or nodules appear in the affected area progressing to scaly and verrucose plaques. Direct examinations of skin scrapings or histopathologic study demonstrates the typical muriform bodies. Microbiologic culture is necessary for the correct determination of the etiologic agent. Itraconazole is the treatment of choice, often in combination with surgery. Even so, results are often unsatisfactory as patients present late to medical services because of lack of funds and the fact that the disease usually affects the main family earner.

Citing Articles

Chromoblastomycosis caused by , concurrent with myiasis, in a recipient of a kidney transplant: a compelling case report.

Mahmoudi H, Ramezanalipour Z, Khansari M, Meijer E, Mahmoudi S, Spruijtenburg B Front Med (Lausanne). 2024; 11:1396224.

PMID: 39081689 PMC: 11286409. DOI: 10.3389/fmed.2024.1396224.


From Child to Old Man: A Slowly Evolving Case of Chromoblastomycosis Caused by .

Rodriguez-Cerdeira C, Hernandez-Castro R, Arenas R, Sandoval-Tress C, Gutierrez-Murillo F, Martinez-Chavarria L Antibiotics (Basel). 2023; 12(12).

PMID: 38136747 PMC: 10741158. DOI: 10.3390/antibiotics12121713.


New Immunological Markers in Chromoblastomycosis-The Importance of PD-1 and PD-L1 Molecules in Human Infection.

Cavallone I, Belda Jr W, de Carvalho C, Laurenti M, Passero L J Fungi (Basel). 2023; 9(12).

PMID: 38132773 PMC: 10744586. DOI: 10.3390/jof9121172.


Chromoblastomycosis: New Perspective on Adjuvant Treatment with Acitretin.

Belda Jr W, Passero L, de Carvalho C, Mojica P, Vale P Diseases. 2023; 11(4).

PMID: 37987273 PMC: 10660773. DOI: 10.3390/diseases11040162.


Urban chromoblastomycosis: a diagnosis that should not be neglected.

Baka J, Giraldelli G, Bernardes-Engemann A, Barcaui C, Orofino-Costa R An Bras Dermatol. 2023; 98(3):422-425.

PMID: 36746731 PMC: 10173060. DOI: 10.1016/j.abd.2022.01.013.